Fishawack Health, a UK-based global commercialisation partner for the modern life science era, announced on Tuesday that it has named Jonathan (Jon) Koch as its new chief executive officer.
In the new role, Koch is to lead Fishawack Health through its next stage of growth, which is focused on building and retaining talented teams and delivering a complete set of integrated services for customers across the life science industry.
Koch has spent his complete career in the healthcare sector, including around 12 years at Covance as group president of Clinical Development and Commercialisation services. He has served as senior vice president and CEO of Global Dental at Henry Schein.
EDX Medical to provide molecular profiling services to Astron Health
Futura Medical appoints Market Performance Group as new US distribution partner for Eroxon
MaaT Pharma to seek review after CHMP negative opinion on MaaT013 application
Sensei Biotherapeutics changes name to Faeth Therapeutics
Datavault AI and Wellgistics Health plan DelivMeds AI healthcare venture
Intensity Therapeutics receives Cancer Treatment Technology Innovator of the Year award
Solvonis Therapeutics appoints Water Tower Research to strengthen US market positioning
Atrium Therapeutics announces inducement grants to seven new employees